We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CI:NYSEThe Cigna Group analysis

Data as of Oct 14, 2026 - not real-time

Latest price
$289.78
Risk: low
3/10Low risk

Summary

The moving-average structure behind The Cigna Group is bearish at $289.78, with short-term averages lagging the long-term ones. It has gained 2.4% over the past 30 days. Momentum indicators put RSI at 64.5 (approaching overbought) with MACD reading bullish. Watch $262.85 as support and $290.08 as the nearer resistance level.
Multiples put this in undervalued territory: 12.0 times earnings against the sector's 31.0. Sell-side targets cluster 18.1% above the current quote. Revenue is growing at 6.7% on a 2.3% profit margin. The 2.21% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 23.1%, a beta of 0.19 and a maximum drawdown of 20.9%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons line up on buy — conviction 7 out of 10.

Top market events

  • Revenue hit USD 71.70 billion in second-quarter 2026, up 7.00 percent. Cigna Group stock costs EUR 2
  • Revenue reached USD 71.70 billion in the second quarter of 2026 versus USD 70.18 billion consensus.
  • Cigna Group stock was at EUR 242.85 at Lang & Schwarz on September 30, 2026. The company reaffirmed

Market outlook

Short term

< 1 year

Positive

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading above the 200-day average of 280.19
  • MACD momentum is positive

Medium term

1–3 years

Positive

Model confidence5/105 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 12.0 versus sector average of 31.0
  • Trading above the 200-day average of 280.19

Long term

> 3 years

Positive

Model confidence7/107 out of 10

Key factors

  • P/E of 12.0 versus sector average of 31.0
  • Analyst targets imply +18.1% versus the current price
  • Return on equity of 16.8%

Key metrics

Financial health

Revenue Growth6.70%
Profit Margin2.27%
P/E Ratio12.0
ROE16.76%
ROA4.46%
Debt/Equity74.29
P/B Ratio1.8
Op. Cash Flow$10.3B
Free Cash Flow$8.0B
Industry P/E31.0

Technical analysis

TrendBearish
RSI64.5
Support$262.85
Resistance$290.08
MA 20$275.30
MA 50$277.81
MA 200$280.19
MACDBullish
VolumeDecreasing
Fear & Greed Index91.11

Valuation

Fair Value$383.60
Target Price$342.29
Upside/Downside18.12%
GradeUndervalued
TypeBlend
Dividend Yield2.21%

Risk assessment

Beta0.19
Volatility23.05%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.